CLINICAL_TRIALS
trial_result
· 2025-12-09
Clinical Trial Update: A Extension Study of Udenafil in Adolescents [Phase 3]
Summary
An extension study of udenafil in adolescents with single ventricle heart disease has completed Phase 3 and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mezzion Pharma Co. Ltd | Conditions: Functional Single Ventricle Heart Disease | Phase 3 | Status: COMPLETED | Results posted: 2025-12-09